27.04.2016 10:45:00
|
Vetoquinol Publishes Its Registration Document and Its Annual Financial Report Relative to Fiscal Year 2015 (French Version)
Regulatory News:
The Registration document of Vetoquinol (Paris:VETO) relative to fiscal year 2015, including the Annual financial report relative to fiscal year 2014, was filed with the Autorité des marchés financiers ("the AMF”) on April 26, 2016.
It can be read or downloaded on the websites of:
- VETOQUINOL (www.vetoquinol.com)
- the AMF (www.amf-france.org)
It is also available to the public free of charge upon simple request:
- by mail:
Vetoquinol
Communication financière
Magny-Vernois – BP
189 – 70204 Lure Cedex - France
- by e-mail: relations.investisseurs@vetoquinol.com
- by phone: +33 (0)3 84 62 59 88
The registration document integrates among other:
- the report of the President of the Board of directors on the corporate governance and on the internal control established upon provisions of article L. 225-37 of the French Commercial code;
- the management report;
- the sustainable development report;
- the statutory auditors' reports;
- the information relative to the fees paid to the statutory auditors.
Next update: First half 2016 results - July 28, 2016 after market close
About Vetoquinol
Vetoquinol is a leading global
player in the animal health sector serving both the livestock (cattle
and pigs) and pet (dogs and cats) markets.
An independent
pure player, Vetoquinol designs, develops and sells veterinary drugs and
non-medicinal products in Europe, the Americas and the Asia Pacific
region.
Since its foundation in 1933, Vetoquinol has pursued
a strategy combining innovation with geographical diversification. The
Group's hybrid growth is driven by the reinforcement of its product
portfolio coupled with acquisitions in high potential growth markets.
Vetoquinol employs over 2,000 people.
Vetoquinol has been
listed on NYSE Euronext Paris since 2006 (symbol: VETO).
For further information, go to: www.vetoquinol.com.
VETOQUINOL – 34 rue du Chêne Sainte Anne - Magny-Vernois – 70204 Lure
Cedex – France
www.vetoquinol.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160427005663/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VETOQUINOLmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu VETOQUINOLmehr Analysen
Aktien in diesem Artikel
VETOQUINOL | 67,30 | 2,75% |